Could AI diagnosis help progress brain tumour treatment? The Brain Tumour Charity has collaborated with the Grace Kelly Childhood Cancer Trust to fund the exploration of its possibilities.
Founded in 2016, the Grace Kelly Childhood Cancer Trust fund research into rare and aggressive childhood cancers, educate families and clinicians about the signs and symptoms of childhood cancer and produce information booklets to explain to parents and children about the treatments they are facing.
Together, we’re co-funding a new research project that aims to use artificial intelligence to help ensure a faster, more accurate diagnosis for children with brain tumours.
Using artificial intelligence to help diagnose paediatric brain tumours
This ambitious project led by Dr John Apps will take MIROR – a new AI tool developed to improve brain tumour diagnosis – and see how accurately it can diagnose brain tumours in children in real-world hospital settings.
MIROR allows clinicians to analyse a new MRI scan, compare it with scans of known tumour types and receive a prediction of the likely tumour type. Currently, it can take several weeks to get this information by analysing a biopsy of the tumour.
Dr John Apps
Dr John Apps is an Academic Paediatric Neuro-oncologist working between the University of Birmingham and Birmingham Children’s Hospital. His research interests include craniopharyngioma and rare brain tumours; imaging, data integration and artificial intelligence and clinical trials.
We’re proud to be co-funding this pioneering research project with the Grace Kelly Childhood Cancer Trust. By embracing new technologies like advanced MRI imaging and AI, this work could significantly speed up diagnosis for children with brain tumours – helping families get answers faster during an incredibly difficult time.
-Dr Michele Afif, Chief Executive Officer of The Brain Tumour Charity
The Grace Kelly Childhood Cancer Trust has been pleased to support the important work being carried out by our colleagues at The Brain Tumour Charity, which focuses on breaking down barriers within primary care that may contribute to delays in diagnosing brain tumours in both children and adults. Sadly, delays in diagnosis continue to occur in a number of cases, so collaborations such as this are crucial in helping to improve outcomes through shared expertise and coordinated efforts.
– Dr Jen Kelly, Chief Executive Officer of The Grace Kelly Childhood Cancer Trust